BENITIONSClinical Trial Intelligence

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

단계 해당 없음 완료 NCT04227379

대상 질환Diabetes Mellitus, Type 2
임상 단계단계 해당 없음
스폰서VA Office of Research and Development
상태완료
참여자 수366 명
중재(약물)Intervention 1- DSMS+, Comparison - DSMS
시작일2023년 1월 30일
완료일2025년 4월 30일
결과 공개일2026년 6월 1일

요약

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Change in HbA1c Percent Time in Control

pre-enrollment, 6 month follow up · percent (%) of time in control

DSMS23.41 ± 34.96 percent (%) of time in control
DSMS+ (DSMS Plus)21.61 ± 40.55 percent (%) of time in control
p-value.6519
Mean Difference (Net)1.80 (95% CI -6.05–9.65)

Change in HbA1c

pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin

DSMS-0.36 ± 1.37 Percentage of glycosylated hemoglobin
DSMS+ (DSMS Plus)-0.40 ± 1.29 Percentage of glycosylated hemoglobin
p-value.7552
Mean Difference (Net).05 (95% CI -.25–.34)

BENITIONS에서 보기 ClinicalTrials.gov 원문 보기

같은 질환의 다른 임상

전체 임상

이 페이지는 ClinicalTrials.gov의 공개 데이터를 정리한 것입니다. 의학적 조언이 아니며 투자 권유나 자문도 아닙니다. 반드시 전문의와 상담하세요.